Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

IL-10 induces TGF-β secretion, TGF-β receptor II upregulation, and IgA secretion in B cells

  • 8 Accesses


Background: Interleukin-10 (IL-10) is a pleiotropic cytokine, which has both regulatory and stimulatory effects on different immune cell types. Different studies have reported the importance of IL-10 and Transforming growth factor-beta (TGF-p) in the regulation of B cell class switching the production of immunoglobulin A (IgA); however, the underlying mechanisms remain to be fully elucidated. The objective of this study was to investigate the TGF-p response during B stimulation of human B cells by IL-10. Methods: Pan B cells of healthy donors were negatively purified by a magnetic cell separation technique. B cells were cultured with multimeric CD40 ligand (mCD40L) and IL-10 for two and seven days. After harvesting in specific days, TGF-p receptor II and surface IgA expression was determined by flow cytometry, while IgA and TGF-p secretion was assessed by enzyme-linked immunosorbent assay. Results: B cells endogenously expressed TGF-p receptor II and after 48 hours cultivation with mCD40L or mCD40L plus IL-10, both the expression of this receptor and the production of TGF-p were significantly increased. Notably, TGF-p levels following stimulation with mCD40L and IL-10 were higher than those produced by B cells stimulated with mCD40L alone. Furthermore, at day 7 and following IL-10 stimulation, there was a significant rise in the amount of IgA secretion by class-switched plasma cells, which was higher than stimulation with mCD40L alone. Conclusion: Our findings suggest that IL-10 can modulate TGF-p production and TGF-p receptor expression in mCD40-activated human B lymphocytes.

This is a preview of subscription content, log in to check access.


  1. 1.

    Heldin CH, Moustakas A. Signaling receptors for TGF-beta family members. Cold Spring Harb Perspect Biol 2016; 8(8): a022053.

  2. 2.

    Pircher R, Jullien P, Lawrence DA. Beta-transforming growth factor is stored in human blood platelets as a. atent high molecular weight complex. Biochem Biophys Res Commun 1986; 136(1):30–7.

  3. 3.

    Lawrence DA. Latent-TGF-beta: an overview. Mol Cell Biochem 2001; 219(1-2):163–70.

  4. 4.

    Schultz-Cherry S, Ribeiro S, Gentry L, Murphy-Ullrich JE. Thrombospondin binds and activates the small and large forms of latent transforming growth factor-beta in a. hemically defined system. J Biol Chem 1994; 269(43):26775–82.

  5. 5.

    Millan FA, Denhez F, Kondaiah P, Akhurst RJ. Embryonic gene expression patterns of TGF beta 1, beta 2 and beta 3 suggest different developmental functions in vivo. Development 1991; 111(1):131–43.

  6. 6.

    Gatza CE, Oh SY, Blobe GC. Roles for the type III TGF-b receptor in human cancer. Cell Signal 2010; 22(8): 1163–74.

  7. 7.

    Massague J. A. ery private TGF-b receptor embrace. Mol Cell 2008; 29(2): 149–50.

  8. 8.

    Aazami H, Seif F, Ghalehbaghi B, et al. Levels of total IgA and IgA subclasses in the serum of chronic rhinosinusitis patients. Med J. am Repub Iran 2018; 32:94.

  9. 9.

    Chen W, ten Dijke P. Immunoregulation by members of the TGFb superfamily. Nat Rev Immunol 2016; 16(12):723.

  10. 10.

    Bagheri Y, Sanaei R, Yazdani R, et al. The heterogeneous pathogenesis of selective immunoglobulin A. eficiency. Int Arch Allergy Immunol 2019; 179(3):232–46.

  11. 11.

    Santibanez JF, Quintanilla M, Bernabeu C. TGF-beta/TGF-beta receptor system and its role in physiological and pathological conditions. Clin Sci (Lond) 2011; 121(6):233–51.

  12. 12.

    Moore KW, de Waal Malefyt R, Coffman RL, O’Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001; 19:683–765.

  13. 13.

    Conti P, Kempuraj D, Kandere K, et al. IL-10, an inflammatory/ inhibitory cytokine, but not always. Immunol Lett 2003; 86 (2): 123–9.

  14. 14.

    Rousset F, Garcia E, Defrance T, et al. Interleukin 10 is a. otent growth and differentiation factor for activated human B. ymphocytes. Proc Natl Acad Sci USA 1992; 89 (5): 1890–3.

  15. 15.

    Burdin N, Van Kooten C, Galibert L, et al. Endogenous IL-6 and IL-10 contribute to the differentiation of CD40-activated human B. ymphocytes. J Immunol 1995; 154(6):2533–44.

  16. 16.

    Heine G, Drozdenko G, Grun JR, Chang HD, Radbruch A, Worm M. Autocrine IL-10 promotes human B-cell differentiation into IgM- or IgG-secreting plasmablasts. Eur J. mmunol 2014;44(6):1615–21.

  17. 17.

    Defrance T, Vanbervliet B, Briere F, Durand I, Rousset F, Banchereau J. Interleukin 10 and transforming growth factor beta cooperate to induce anti-CD40-activated naive human B. ells to secrete immunoglobulin A. J Exp Med 1992; 175(3): 671–82.

  18. 18.

    Mocellin S, Panelli MC, Wang E, Nagorsen D, Marincola FM. The dual role of IL-10. Trends Immunol 2003; 24(1): 36–43.

  19. 19.

    Liu Y, Wei SH, Ho AS, de Waal Malefyt R, Moore KW. Expression cloning and characterization of a. uman IL-10 receptor. J Immunol 1994; 152(4):1821–9.

  20. 20.

    Tan JC, Indelicate SR, Narula SK, Zavodny PJ, Chou CC. Characterization of interleukin-10 receptors on human and mouse cells. J Biol Chem 1993; 268(28):21053–9.

  21. 21.

    Kato H, Whiteside TL. Expression of IL-10 and IL-10 receptors on peripheral blood lymphocytes and monocytes in human head and neck squamous cell carcinoma. Tokai J. xp Clin Med 2011: 36(4):144–51.

  22. 22.

    Dennler S, Goumans MJ, ten Dijke P. Transforming growth factor beta signal transduction. J. Leukoc Biol 2002; 71(5): 731–40.

  23. 23.

    Zan H, Cerutti A, Dramitinos P, Schaffer A, Casali P. CD40 engagement triggers switching to IgAl and IgA2 in human B. ells through induction of endogenous TGF-b: evidence for TGF-b but not IL-10-dependent direct Sm → Sa. nd sequential Sm → Sg, Sg → Sa. NA. ecombination. J Immunol 1998; 161 (10):5217–25.

  24. 24.

    Garcia-Marquez MA, Shimabukuro-Vornhagen A, Theurich S, et al. A multimerized form of recombinant human CD40 ligand supports long-term activation and proliferation of B. ells. Cytotherapy 2014; 16(11): 1537–44.

  25. 25.

    Cerutti A. The regulation of IgA class switching. Nat Rev Immunol 2008; 8(6):421–34.

  26. 26.

    Islam KB, Nilsson L, Sideras P, Hammarstrom L, Smith CI. TGF-beta 1 induces germ-line transcripts of both IgA subclasses in human B. ymphocytes. Int Immunol 1991; 3(11): 1099–106.

  27. 27.

    Kehrl JH, Roberts AB, Wakefield LM, Jakowlew S, Sporn MB, Fauci AS. Transforming growth factor beta is an important immunomodulatory protein for human B. ymphocytes. J Immunol 1986; 137(12):3855–60.

  28. 28.

    Cottrez F, Groux H. Regulation of TGF-beta response during T. ell activation is modulated by IL-10. J Immunol 2001; 167 (2):773–8.

  29. 29.

    Walter MR. The molecular basis of IL-10 function: from receptor structure to the onset of signaling. Curr Top Microbiol Immunol 2014; 380: 191–212.

  30. 30.

    Behniafard N, Amirzargar A, Gharagozlou M, et al. Single nucleotide polymorphisms of the genes encoding IL-10 and TGF-bl in Iranian children with atopic dermatitis. Allergol Immunopathol 2018; 46(2): 155–9.

  31. 31.

    Tavakol M, Movahedi M, Amirzargar AA, et al. Association of interleukin 10 and transforming growth factor b. ene polymorphisms with chronic idiopathic urticaria. Acta Dermatovenerol Croat 2014; 22(4):239.

  32. 32.

    Rezaei N, Aghamohammadi A, Shakiba Y, et al. Cytokine gene polymorphisms in common variable immunodeficiency. Int Arch Allergy Immunol 2009; 150(1):1–7.

Download references

Author information

Correspondence to Mehdi Shekarabi or Asghar Aghamohammadi.

About this article

Verify currency and authenticity via CrossMark

Cite this article

Bagheri, Y., Babaha, F., Falak, R. et al. IL-10 induces TGF-β secretion, TGF-β receptor II upregulation, and IgA secretion in B cells. Eur Cytokine Netw 30, 107–113 (2019).

Download citation


  • immunoglobulin A
  • interleukin-10
  • transforming growth factor-beta
  • class switching